- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1432-0851
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Vedolizumab treatment for immune checkpoint inhibitor-induced enterocolitis ; day:15 ; month:2 ; year:2017 ; pages:1-12
Cancer immunology immunotherapy ; (15.2.2017), 1-12
- Keyword
-
Krebs
Onkologie
- Creator
-
Bergqvist, Viktoria
- Contributor
-
Hertervig, Erik
Gedeon, Péter
Kopljar, Marija
Griph, Håkan
Kinhult, Sara
Carneiro, Ana
Marsal, Jan
SpringerLink (Online service)
- DOI
-
10.1007/s00262-017-1962-6
- URN
-
urn:nbn:de:1111-201703103135
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:47 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Bergqvist, Viktoria
- Hertervig, Erik
- Gedeon, Péter
- Kopljar, Marija
- Griph, Håkan
- Kinhult, Sara
- Carneiro, Ana
- Marsal, Jan
- SpringerLink (Online service)
Other Objects (12)
The Role of Abdominal Surgery in Refractory Immune Checkpoint Inhibitor Enterocolitis: A Case Report
Outcomes of vedolizumab therapy in patients with immune checkpoint inhibitor–induced colitis: a multi-center study
Gut microbiota shifts from onset to remission in immune checkpoint inhibitor-induced enterocolitis: a case report
Immune Checkpoint Inhibitor Rechallenge After Prior Immune Toxicity
Immune checkpoint inhibitor-related acral vasculitis
Cancer immunotherapy beyond immune checkpoint inhibitors
Taking the bull by the horn: the frontline use of infliximab for the treatment of immune checkpoint inhibitor-induced enterocolitis
Thyroid disorders induced by immune checkpoint inhibitors
Kutane Nebenwirkungen unter Immun-Checkpoint-Inhibitor-Therapie
Immune Checkpoint Inhibitor Therapy in Neuroendocrine Tumors
Cardiotoxicity risk factors with immune checkpoint inhibitors
Immune checkpoint inhibitors for multiple myeloma immunotherapy
The Role of Abdominal Surgery in Refractory Immune Checkpoint Inhibitor Enterocolitis: A Case Report
Outcomes of vedolizumab therapy in patients with immune checkpoint inhibitor–induced colitis: a multi-center study
Gut microbiota shifts from onset to remission in immune checkpoint inhibitor-induced enterocolitis: a case report
Immune Checkpoint Inhibitor Rechallenge After Prior Immune Toxicity
Immune checkpoint inhibitor-related acral vasculitis
Cancer immunotherapy beyond immune checkpoint inhibitors
Taking the bull by the horn: the frontline use of infliximab for the treatment of immune checkpoint inhibitor-induced enterocolitis
Thyroid disorders induced by immune checkpoint inhibitors
Kutane Nebenwirkungen unter Immun-Checkpoint-Inhibitor-Therapie
Immune Checkpoint Inhibitor Therapy in Neuroendocrine Tumors
Cardiotoxicity risk factors with immune checkpoint inhibitors
Immune checkpoint inhibitors for multiple myeloma immunotherapy
The Role of Abdominal Surgery in Refractory Immune Checkpoint Inhibitor Enterocolitis: A Case Report
Outcomes of vedolizumab therapy in patients with immune checkpoint inhibitor–induced colitis: a multi-center study
Gut microbiota shifts from onset to remission in immune checkpoint inhibitor-induced enterocolitis: a case report
Immune Checkpoint Inhibitor Rechallenge After Prior Immune Toxicity
Immune checkpoint inhibitor-related acral vasculitis
Cancer immunotherapy beyond immune checkpoint inhibitors
Taking the bull by the horn: the frontline use of infliximab for the treatment of immune checkpoint inhibitor-induced enterocolitis
Thyroid disorders induced by immune checkpoint inhibitors
Kutane Nebenwirkungen unter Immun-Checkpoint-Inhibitor-Therapie
Immune Checkpoint Inhibitor Therapy in Neuroendocrine Tumors
Cardiotoxicity risk factors with immune checkpoint inhibitors